Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897403 · ClinicalTrials.gov registry record
Blood and Tissue Sample Collection for Future Colon Cancer Biomarker Studies in Patients Undergoing Colonoscopy
A clinical trial of Colorectal Cancer and Health Status Unknown, sponsored by Vanderbilt University.
- Completed
- Registry status
- 6,446
- Enrollment target
- 4
- Study locations
NCT00897403 is a study of Colorectal Cancer and Health Status Unknown that has completed, run by Vanderbilt University. The registered enrollment target is 6,446 participants, above the 1,494-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (331% higher). The trial reports 4 study locations across 1 state.
The verdict
NCT00897403, a study of Colorectal Cancer and Health Status Unknown, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 6,446 participants
- Enrollment target
- 4
- Study locations
Study Summary
RATIONALE: Collecting and storing samples of blood and tissue from patients undergoing colonoscopy to study in the laboratory may help doctors learn more about colon cancer and identify biomarkers related to colon cancer in the future. PURPOSE: This laboratory study is collecting blood and tissue samples for future colon cancer biomarker studies in patients undergoing colonoscopy.
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
- PROCEDURE diagnostic colonoscopy
Study Locations (4)
Tennessee
- Vanderbilt-Ingram Cancer Center - Cool Springs - Nashville
- Vanderbilt-Ingram Cancer Center at Franklin - Nashville
- Dan Rudy Cancer Center at Saint Thomas Hospital - Nashville
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,446 participants |
| Start Date | 2006-12 |
| Est. Completion | 2016-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00897403
The ClinicalTrials.gov registry entry for NCT00897403 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,446 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,494-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (331% higher). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which biologic sample preservation procedure is the first listed.
NCT00897403 reports 4 study locations spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00897403 about?
NCT00897403 is a clinical study titled "Blood and Tissue Sample Collection for Future Colon Cancer Biomarker Studies in Patients Undergoing Colonoscopy". RATIONALE: Collecting and storing samples of blood and tissue from patients undergoing colonoscopy to study in the laboratory may help doctors learn more about colon cancer and identify biomarkers related to colon cancer in the future. PURPOSE: This laboratory study is collecting blood and tissue s...
What is the current status of trial NCT00897403?
This trial is currently completed. The enrollment target is 6,446 participants. The study started on 2006-12. Estimated completion is 2016-04.
What conditions does trial NCT00897403 study?
This clinical trial studies the following conditions: Colorectal Cancer, Health Status Unknown.
What interventions are being tested in trial NCT00897403?
The interventions under investigation include: biologic sample preservation procedure (OTHER), diagnostic colonoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT00897403?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00897403 being conducted?
This trial has 4 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.